EuroPCR 23: 3 Trials That Will Change Your Practice With Dr Mirvat Alasnag

We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have an impact on interventional science and clinical practice.
Trials covered in detail include:
EBC TWO Five-Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction
KISS: Provisional Stenting in Bifurcation Lesion: Benefit of Side Branch Intervention
Recorded on-site at EuroPCR 2023, Paris.
Visit Radcliffe Cardiology: www.radcliffecardiology.com/
Visit Radcliffe Vascular: www.radcliffevascular.com/
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: / radcliffecardiology
Follow us on X: x.com/radcliffeCARDIO